Very long chain fatty acids activate NADPH oxidase in human dermal fibroblasts

被引:27
作者
Dhaunsi, GS
Kaur, J
Alsaeid, K
Turner, RB
Bitar, MS
机构
[1] Kuwait Univ, Fac Med, Dept Pediat, Kuwait 13110, Kuwait
[2] Kuwait Univ, Fac Med, Dept Pharmacol, Kuwait 13110, Kuwait
[3] Univ Virginia, Dept Pediat, Charlottesville, VA USA
关键词
VLCFAs; peroxisome; NADPH oxidase; fibroblasts; superoxide; lipid peroxidation;
D O I
10.1002/cbf.1173
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Very long chain fatty acids (VLCFAs) are exclusively oxidized in peroxisomes and their levels are significantly increased in tissues of patients with peroxisomal disorders. Although the biochemical indicators of peroxisomal dysfunction, such as elevated VLCFAs, are well known, the mechanisms of pathogenesis of peroxisomal diseases are unclear. In this study we have examined the effect of VLCFAs on NADPH oxidase (NOX), a complex enzyme system responsible for the production of superoxide anions, in order to understand the oxidative stress-mediated mechanisms involved in pathology of peroxisomal disorders. Varying concentrations (2.5 to 10 mug ml(-1)) of VLCFAs, lignoceric acid and cerotic acid, significantly (p < 0.001) increased the enzymic activity of NOX in cultures of human dermal fibroblasts. VLCFAs did not affect the expression of gp91phox or p22phox whereas the mRNA and protein levels of p47phox were significantly (two or three-fold) increased following treatment of fibroblasts with lignoceric acid or cerotic acid. VLCFAs also caused a significant (p < 0.01) increase in lipid peroxidation in dermal fibroblasts which could be markedly reversed by treatment with apocyanin (10 mm) or superoxide dismutase (SOD, 25 U ml(-1)). With these results, we report for the first time that VLCFAs enhance NOX activity and superoxide anion-mediated lipid peroxidation in cultured dermal fibroblasts. This study proposes a mechanism that may be taking place in vivo during peroxisomal dysfunction and that leads to oxidative stress-mediated pathogenesis. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:65 / 68
页数:4
相关论文
共 23 条
[11]   Low-density lipoprotein stimulated peroxide production and endocytosis in cultured human endothelial cells: Mechanisms of action [J].
Holland, JA ;
Meyer, JW ;
Schmitt, ME ;
Sauro, MD ;
Johnson, DK ;
AbdulKarim, RW ;
Patel, V ;
Ziegler, LM ;
Schillinger, KI ;
Small, RF ;
Lemanski, LF .
ENDOTHELIUM-NEW YORK, 1997, 5 (03) :191-207
[12]  
KREMSER K, 1995, WIEN KLIN WOCHENSCHR, V107, P690
[13]   Novel homologs of gp91phox [J].
Lambeth, JD ;
Cheng, GJ ;
Arnold, RS ;
Edens, WA .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (10) :459-461
[14]   PEROXISOMAL DISORDERS [J].
MOSER, HW .
CLINICAL BIOCHEMISTRY, 1991, 24 (04) :343-351
[15]   Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s [J].
Pattison, DI ;
Dean, RT ;
Davies, MJ .
TOXICOLOGY, 2002, 177 (01) :23-37
[16]   The role of peroxisomes in aging [J].
Périchon, R ;
Bourre, JM ;
Kelly, JF ;
Roth, GS .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1998, 54 (07) :641-652
[17]   Clinical approach to inherited peroxisomal disorders [J].
PoggiTravert, F ;
Fournier, B ;
PollThe, BT ;
Saudubray, JM .
JOURNAL OF INHERITED METABOLIC DISEASE, 1995, 18 :1-18
[18]   PEROXISOMAL DISORDERS - A NEWLY RECOGNIZED GROUP OF GENETIC-DISEASES [J].
SCHUTGENS, RBH ;
HEYMANS, HSA ;
WANDERS, RJA ;
VANDERBOSCH, H ;
TAGER, JM .
EUROPEAN JOURNAL OF PEDIATRICS, 1986, 144 (05) :430-440
[19]   Genetic, biochemical, and clinical features of chronic granulomatous disease [J].
Segal, BH ;
Leto, TL ;
Gallin, JI ;
Malech, HL ;
Holland, SM .
MEDICINE, 2000, 79 (03) :170-200
[20]  
Selishcheva A A, 2001, Membr Cell Biol, V14, P637